No-Mask radiation therapy: a comfortable alternative for head and neck cancer patients?

NCT ID NCT03076255

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tested a new maskless immobilization device (MID) for patients with head and neck cancers or brain tumors undergoing radiation therapy. The goal was to see if the device could keep patients as still and accurate as the standard thermoplastic mask. Only 12 patients were enrolled, and the study measured how much movement occurred during treatment. Results may lead to a more comfortable option for patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Maskless immobilization device (MID)

What this could lead to

If successful, this device could offer a more comfortable alternative to thermoplastic masks for patients undergoing radiation therapy for head and neck cancers or brain tumors.

What could go wrong

This is a very small pilot study with only 12 participants, so results may not apply to all patients. The device may not be as accurate or reliable as standard masks in larger studies.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

brain cancer brain neoplasm head and neck cancer Head and Neck Neoplasms Neurologic Manifestations

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Sidney Kimmel Cancer Center at Thomas Jefferson University

    Philadelphia, Pennsylvania, 19107, United States